Ready-to-go T cells may be responsible for immunotherapy success in Hodgkin lymphoma

Retrieved on: 2024-04-04 17:51:54

Tags for this article:

Immune system

T cells

Programmed cell death protein 1

Tumor microenvironment

the university of chicago medicine

Click the tags to see associated articles and topics

Ready-to-go T cells may be responsible for immunotherapy success in Hodgkin lymphoma. View article details on HISWAI: https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/hodgkin-lymphoma-t-cells

Excerpt

Their insights could advance immunotherapy as an effective treatment for cHL. This rare cancer of the immune system primarily affects adults in their ...

Article found on: www.uchicagomedicine.org

View Original Article